Close Menu

NEW YORK (GenomeWeb) — The National Institutes of Health this week announced that it has earmarked $28 million over the next four years to fund the study and refinement of clinical measures of social impairment in autism spectrum disorder.

The effort, which is being led by Yale School of Medicine's James McPartland, is being supported under the Biomarkers Consortium, a research partnership of industry, government, and academic groups focused on identifying and validating biomarkers for a variety of diseases.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.